Cytosorbents (CTSO) Inventory (2011 - 2026)

Cytosorbents (CTSO) has reported Inventory for 16 consecutive years, with $3.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory fell 0.65% year-over-year to $3.7 million; the trailing twelve-month figure through Jun 2026 stood at $3.7 million (down 0.65% YoY), and the FY2025 full-year result was $5.3 million, up 93.67% from the prior year.
• Inventory fell to $3.7 million in Q2 2026 per CTSO's latest filing, from $4.5 million in the prior quarter.
• Across five years, Inventory topped out at $5.4 million in Q1 2022 and bottomed at $1.7 million in Q1 2023.
• Historically, Inventory has averaged $3.7 million across 5 years, with a median of $3.6 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Inventory tumbled 68.31% in 2023, then jumped 116.66% in 2024.
• Over 5 years, Inventory stood at $3.5 million in 2022, then decreased by 2.48% to $3.4 million in 2023, then fell by 19.04% to $2.7 million in 2024, then soared by 93.67% to $5.3 million in 2025, then tumbled by 30.36% to $3.7 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $3.7 million, $4.5 million, and $5.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.